Skip to main content

Together we are beating cancer

Donate now

News

Showing 12 out of 2977 results
Lung cancer cells seen through a microscope, in shades of purple and green,

Cancer Grand Challenges is offering up to £20m funding to teams that can answer seven of the biggest and most important questions in cancer. Cancer Grand Challenges is offering up to £20m funding to teams that can answer seven of the biggest and most important questions in cancer.

by Tim Gunn | News | 5 March 2025

5 March 2025

A doctor/nurse walking down a corridor in a hospital

Our new report, Cancer in the UK 2025: Socioeconomic deprivation, shows that cancer death rates are nearly 60% higher for people living in the most deprived areas of the UK, with around 28,400 extra cancer deaths each year linked to socioeconomic inequality. Our new report, Cancer in the UK 2025: Socioeconomic deprivation, shows that cancer death rates are nearly 60% higher for people living in the most deprived areas of the UK, with around 28,400 extra cancer deaths each year linked to socioeconomic inequality.

by Amy Warnock | News | 21 February 2025

21 February 2025

A woman reading a cancer information limit while waiting to see the doctor.

New analysis has shown that last year, 74,000 cancer patients didn’t start their treatment on time. That's enough people to fill the O2 arena almost four times over. New analysis has shown that last year, 74,000 cancer patients didn’t start their treatment on time. That's enough people to fill the O2 arena almost four times over.

by Amy Warnock | News | 13 February 2025

13 February 2025

Lab-grown bowel cancer cells seen through a microscope. They are colour-enhanced and appear blue.

A new testing technique with genome sequencing is 90% accurate at predicting which high-risk people with IBD will develop bowel cancer, according to a study by our scientists.  A new testing technique with genome sequencing is 90% accurate at predicting which high-risk people with IBD will develop bowel cancer, according to a study by our scientists. 

by Tim Gunn | News | 30 January 2025

30 January 2025

A group of three Cancer Research UK scientists Group of researchers looking at a data file in a lab

A first-of-its-kind drug that protects the hearing of babies, children and young people undergoing cancer treatment has been approved for NHS use in England, based on the results of one of our trials.   A first-of-its-kind drug that protects the hearing of babies, children and young people undergoing cancer treatment has been approved for NHS use in England, based on the results of one of our trials.  

by Tim Gunn | News | 28 January 2025

28 January 2025

Salmonella bacteria (rod-shaped organisms coloured blue) in a bowel cancer tumour (coloured beige). The bacteria looks like it is rushing into a hole in the tumour tissue.

Our researchers are modifying Salmonella bacteria into a treatment that can work with the immune system to attack bowel cancer from two sides at once. Our researchers are modifying Salmonella bacteria into a treatment that can work with the immune system to attack bowel cancer from two sides at once.

by Tim Gunn, Fiona MacLeod | News | 23 January 2025

23 January 2025

Data centre filled with rows of servers

Today, Cancer Research UK, the National Institute for Health and Care Research (NIHR) and the Engineering and Physical Sciences Research Council (EPSRC) are announcing £10 million to create the Cancer Data-Driven Detection programme, which aims to use data to identify individual cancer risk. Today, Cancer Research UK, the National Institute for Health and Care Research (NIHR) and the Engineering and Physical Sciences Research Council (EPSRC) are announcing £10 million to create the Cancer Data-Driven Detection programme, which aims to use data to identify individual cancer risk.

by Amy Warnock, Graeme Sneddon | News | 22 January 2025

22 January 2025